Table 1.
The relationship of lncRNA-CRNDE and miR-384 expression levels (ΔCt) with clinicopathological factors in HCC tissues
| Characteristics | No. of patients (%) | LncRNA-CRNDE | miR-384 | ||
|---|---|---|---|---|---|
|
|
|||||
| Mean ± SD | P value | Mean ± SD | P value | ||
| Total no. of patients | 87 | ||||
| Age (year) | |||||
| > 60 | 38 (43.7) | 10.65 ± 2.23 | 0.09 | 14.11 ± 1.88 | 0.27 |
| ≤ 60 | 49 (56.3) | 11.87 ± 1.67 | 13.64 ± 1.62 | ||
| Gender | |||||
| Male | 35 (40.2) | 11.74 ± 2.12 | 0.08 | 14.96 ± 1.97 | 0.75 |
| Female | 52 (59.8) | 11.23 ± 2.32 | 14.82 ± 1.38 | ||
| Lymphatic metastasis | |||||
| N0 | 45 (51.7) | 11.93 ± 2.03 | 0.012* | 15.47 ± 1.84 | 0.007** |
| N1-N2 | 42 (48.3) | 9.65 ± 1.81 | 13.55 ± 1.49 | ||
| Distal metastasis | |||||
| M0 | 58 (66.7) | 11.58 ± 2.27 | 0.07 | 13.87 ± 1.80 | 0.47 |
| M1 | 29 (33.3) | 10.17 ± 1.94 | 14.47 ± 1.38 | ||
| TNM stage | |||||
| 0 & I & II | 49 (56.3) | 11.93 ± 2.03 | 0.012* | 14.87 ± 1.84 | 0.021* |
| III & IV | 38 (43.7) | 10.65 ± 1.81 | 13.15 ± 1.49 | ||
*
P < 0.05;
**
P < 0.01.